More
SITE MAP

SterRx is a registered trademark of SterRx, LLC.

Products compounded by SterRx in accordance with Section 503B are statutorily exempt from FDA’s
drug approval and adequate directions for use requirements in FDCA Sections 505 and 502(f)(1).
SterRx compounded formulations are not FDA-approved or reviewed by FDA for safety or efficacy.

Automation is used in compounding, sterilizing, filling and sealing of the finished product. Post-
production processes such as labeling and packing are performed manually.